CHS-0214
CHS-0214-05
Phase 3 small_molecule completed
Quick answer
CHS-0214 for Rheumatoid Arthritis is a Phase 3 program (small_molecule) at Coherus Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Coherus Oncology
- Indication
- Rheumatoid Arthritis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed